CONTENTS:
- E-cigarette regulation: a delicate balance for public health [Editorial]. Tackett A.P., Hébert E.T., Stevens E.M., Wagener T.L., p. 2197-2199.
- Drunk, dangerous and delusional: how legal concept-creep risks overcriminalization [Addiction Opinion and Debate]. Crombag H.S., Child J.J., Sullivan G.R., p. 2200-2207.
- Legal concept-creep and scientific imprecision [Commentary]. Koehler J., p. 2208-2209.
- Balancing compassion, accountability, and causal clarity [Commentary]. MacCoun R.J., p. 2209-2210.
- Debating intoxication: Response to commentaries. Crombag H.S., Child J.J., Sullivan G.R., p. 2210-2212.
- Tramadol use and public health consequences in Iran: a systematic review and meta-analysis. Rostam-Abadi Y., Gholami J., Amin-Esmaeili M., Safarcherati A., Mojtabai R., Ghadirzadeh M.R., et al., p. 2213-2242.
- Global opioid agonist treatment: a review of clinical practices by country. Jin H., Marshall B.D.L., Degenhardt L., Strang J., Hickman M., Fiellin D.A., et al., p. 2243-2254.
- Commentary on Jin et al. (2020): Regulatory and allocative policies inform access to opioid agonist therapy. Priest K.C., p. 2255-2256.
- Aberrations in peripheral inflammatory cytokine levels in substance use disorders: a meta-analysis of 74 studies. Wei Z.X., Chen L., Zhang J.J., Cheng Y., p. 2257-2267.
- Assessing the contribution of alcohol-specific causes to socio-economic inequalities in mortality in England and Wales 2001-16. Angus C., Pryce R., Holmes J., de Vocht F., Hickman M., Meier P., et al., p. 2268-2279.
- Impact of bottle size on in-home consumption of wine: a randomized controlled cross-over trial. Codling S., Mantzari E., Sexton O., Fuller G., Pechey R., Hollands G.J., et al., p. 2280-2292.
- Using ecological momentary assessment (EMA) to explore mechanisms of alcohol-involved HIV risk behavior among men who have sex with men (MSM). Wray T.B., Monti P.M., Kahler C.W., Guigayoma J.P., p. 2293-2302.
- Policy congruence and advocacy strategies in the discourse networks of minimum unit pricing for alcohol and the soft drinks industry levy. Hilton S., Buckton C.H., Henrichsen T., Fergie G., Leifeld P., p. 2303-2314.
- Commentary on Hilton et al. (2020): Expanding social discourse analysis to gain traction on the broad commercial determinants of health. Crosbie E., Schmidt L., p. 2315-2316.
- The unique nature of public stigma toward non-medical prescription opioid use and dependence: a national study. Perry B.L., Pescosolido B.A., Krendl A.C., p. 2317-2326.
- Commentary on Perry et al. (2020): Erasing the stigma of opioid use disorder. Corrigan P.W., p. 2327-2328.
- The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study. Binswanger I.A., Nguyen A.P., Morenoff J.D., Xu S., Harding D.J., p. 2329-2338.
- Characterizing the predictive validity of measures of susceptibility to future use of combustible, vaporized and edible cannabis products in adolescent never-users. Barrington-Trimis J.L., Bae D., Schiff S., Davis J., Unger J.B., Leventhal A.M., p. 2339-2348.
- Association between density of gaming venues in a geographical area and prevalence of insolvency: longitudinal evidence from Australia. Badji S., Black N., Johnston D.W., p. 2349-2356.
- Effect of e-cigarette advertisement themes on hypothetical e-cigarette purchasing in price-responsive adolescents. Barnes A.J., Bono R.S., Rudy A.K., Hoetger C., Nicksic N.E., Cobb C.O., p. 2357-2368.
- Electronic cigarettes, nicotine use trends and use initiation ages among US adolescents from 1999 to 2018. Foxon F., Selya A.S., p. 2369-2378.
- Commentary on Foxon & Selya (2020): Social gradients in long-term health consequences of cigarette use-will adolescent e-cigarette use follow the same trajectory? Moss S.L., Keyes K.M., p. 2379-2381.
- The impact of local smoke-free policies on smoking behaviour among adults in Indonesia: a quasi-experimental national study. Septiono W., Kuipers M.A.G., Ng N., Kunst A.E., p. 2382-2392.
- Estimating the prevalence of problem drug use from drug-related mortality data. Jones H.E., Harris R.J., Downing B.C., Pierce M., Millar T., Ades A.E., et al., p. 2393-2404.
- Commentary on Jones et al. (2020): Using indirect estimation methods of drug use prevalence to address racial and ethnic health disparities. Barocas J.A., p. 2405-2406.
- Response to Commentary on Hancock et al. (2020): Low dead space syringes are just one component of an integrated package of care needed to tackle HCV and social exclusion among people who inject drugs. Kesten J., Ward Z., Hancock E., Ayres R., Neale J., Hussey D., et al., p. 2407-2408.
- Response to Humphreys & Hall (2020): Reducing the risks of distortion in cannabis research. Hamilton I., p. 2408-2409.